Loading
Life sciences · Journal article
Journal Sahélien Des Sciences De La Santé · October 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Introduction:Breast cancer is a heterogeneous disease managed through a multimodal strategy combining surgery, systemic therapies, and radiotherapy. This study aimed to describe the sociodemographic, clinical, pathological, therapeutic, and early outcome characteristics of patients receiving curative-intent radiotherapy at Bogodogo University Hospital.Materials and methods:This single-center retrospective cohort included 98 patients with histologically confirmed breast cancer who completed a first course of curative-intent external beam radiotherapy between April 2023 and December 2025. The administrative censoring date was April 30, 2026.Results:The mean age was 49.7 years and the median age was 48 years. Stage IIIA and IIIB disease accounted for 42.9 % of cases. The median interval from surgery to radiotherapy was 214.5 days (IQR, 130–352; range, 51–739 days). Acute toxicities were documented in 9.2 % of patients and treatment interruptions in 7.1 %. Six deaths had occurred by the censoring date.Conclusion:This cohort showed a substantial proportion of locally advanced breast cancers and prolonged intervals between surgery and radiotherapy.